Unknown

Dataset Information

0

Unique microRNA profiles in EGFR-mutated lung adenocarcinomas

ABSTRACT: We have examined the microRNA expression in 154 lung adenocarcinoma samples and 20 paired normal lung tissue samples and investigated the microRNA expression to clinical variables, EGFR- and KRAS- mutational status and time to progression. 174 samples are analyzed. 154 from lung adenocarcinoma tumor tissue and 20 from paired normal lung tissue samples. No replicates or control samples included.

ORGANISM(S): Homo sapiens

SUBMITTER: Bjaanaes MM 

PROVIDER: S-ECPF-GEOD-48414 | biostudies-other | 2014 Oct

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.
| S-EPMC4235315 | biostudies-literature
Transcriptomics Unique microRNA profiles in EGFR-mutated lung adenocarcinomas
2014-03-10 | E-GEOD-48414 | biostudies-arrayexpress
Genomics Unique microRNA profiles in EGFR-mutated lung adenocarcinomas
2014-03-10 | GSE48414 | GEO
Unknown Unique MicroRNA and mRNA Interactions in EGFR-Mutated Lung Adenocarcinoma.
| S-EPMC6262391 | biostudies-literature
Unknown Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.
| S-EPMC6459478 | biostudies-literature
Unknown A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
| S-EPMC5835934 | biostudies-literature
Unknown Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer.
| S-EPMC6166019 | biostudies-literature
Unknown Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.
| S-EPMC5542222 | biostudies-literature
Unknown High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy.
| S-EPMC7445533 | biostudies-literature
Unknown DOK2 inhibits EGFR-mutated lung adenocarcinoma.
| S-EPMC3821857 | biostudies-literature